News

Kuros Biosciences obtains US patent covering a method for producing osteoinductive materials

Schlieren (Zurich), Switzerland, October 22, 2018 – Kuros Biosciences AG (SIX: KURN) announced that its Dutch subsidiary, Kuros Biosciences BV, has recently been granted the US patent, US 10’064’892, entitled “Method for producing an osteoinductive calcium phosphate and products thus obtained” by the United States Patent and Trademark Office (USPTO). The patent covers...

read more

Free Consultation @Bio-Technopark Schlieren-Zurich

If you'd like to discuss your current challenges with experts, Morgan Sindall is offering you the opportunity of a free consultation exchange. Profit from the chance to discuss your business needs with a Morgan Sindall expert without any obligations. The following topics will be approached: Clinical evaluations Regulatory affairs for medicinal products...

read more

NEUE MDR-/IVDR-REGULIERUNG DER EU: LÖSUNGSANSÄTZE FÜR KMU

Dienstag, 23. Oktober 2018, 16.30 bis 21.00 Uhr IFAS 2018, Messe Zürich Die neuen MDR-/IVDR-Regulierungen stellen die gesamte Medtech-Industrie vor eine grosse operative und strategische Herausforderung, deren Auswirkungen den Geschäftsgang vieler Unternehmen – insbesondere von KMUs – stark beeinträchtigen werden. Diese Veranstaltung, die im Rahmen der IFAS 2018 stattfindet, bringt führende Experten...

read more

Joint Workshop Start Smart and Bio-Technopark Strategic Intellectual Property Management for Start-ups / Spin-offs / SMEs

Challenge Protection of Intellectual Properties (Patents, Designs and Trademarks) is expensive. However, for innovative young companies that need financing it is a must! Questions How can I manage an optimized IP-Portfolio at affordable costs? What do I need to set-up a professional IP-management and what does it cost? How do I put this...

read more